News

The sodium glucose cotransporter 2 (SGLT-2) inhibitor drug dapagliflozin, widely used to treat type 2 diabetes, also shows ...
DelveInsight's Chronic Kidney Disease pipeline report depicts a robust space with 75+ active players working to develop 80+ ...
AstraZeneca continues to impress me with the strong performances of its oncology, cardiovascular, and rare disease franchises ...
We compared the dapagliflozin 10 mg (n = 179) and saxagliptin 5 mg (n = 176 ... This analysis was supported by AstraZeneca. Editorial support was provided by Shelley Narula of in Science ...
Sign up to read this article for free. Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
Patients received Dato-DXd 6 mg/kg once every 3 weeks. The primary end point was objective response rate (ORR) by blinded independent central review. Secondary end points included duration of response ...
AstraZeneca AZN stock has declined 6.4% in the past three months. Although AstraZeneca faces its share of challenges, a significant portion of this price decline is attributed to broader market ...
Today's Research Daily features new research reports on 16 major stocks, including Visa Inc. (V), AstraZeneca PLC (AZN ... fell 41% and liquidity rose to $10.2 million. Ocean Power Technologies ...
BELGRADE, Serbia—Dapagliflozin (Farxiga; AstraZeneca) does not further improve quality of ... or impaired LVEF) to dapagliflozin 10 mg once daily or standard care, was the first trial to extend those ...
AstraZeneca manufactures Farxiga, one of the drugs selected in the first round of drug price negotiations under the Program. Farxiga (dapagliflozin) is used to treat diabetes, heart disease ...
Use of the AstraZeneca Dapagliflozin Patient Identification Resource (DAPA-id) to identify patients in your practice who may benefit from taking dapagliflozin. • Opportunities to improve your practice ...
ABU DHABI: The Abu Dhabi Public Health Centre (ADPHC) and AstraZeneca FZ LLC (AstraZeneca) have signed a Memorandum of Understanding (MoU) to launch a collaborative public health project to strengthen ...